Amgen (AMGN) capital expenditure was $1.9B in FY2025 (+70% YoY). The tables below show the complete quarterly and annual capital expenditure history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Capital Expenditure
Fiscal Year
Capital Expenditure
YoY
2025
$1.9B
+70%
2024
$1.1B
-1%
2023
$1.1B
+19%
2022
$936M
+6%
2021
$880M
+45%
2020
$608M
-2%
2019
$618M
-16%
2018
$738M
+11%
2017
$664M
-21%
2016
$837M
+29%
2015
$649M
-35%
2014
$1.0B
+45%
2013
$693M
-3%
2012
$714M
+26%
2011
$567M
-2%
2010
$580M
+9%
2009
$530M
-21%
2008
$672M
-47%
2007
$1.3B
Recent Quarterly Capital Expenditure
Quarter
Capital Expenditure
Q1 2026
$712M
Q4 2025
$642M
Q3 2025
$436M
Q2 2025
$369M
Q1 2025
$411M
Q4 2024
$371M
Q3 2024
$257M
Q2 2024
$238M
Q1 2024
$230M
Q4 2023
$249M
Q3 2023
$248M
Q2 2023
$271M
Source: AMGN on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.